These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 873878)

  • 1. Influence of other antimicrobial agents on the microbiological assay of ethambutol.
    Gangadharam PR; Candler ER; Ramakrishna PV
    J Antimicrob Chemother; 1977 May; 3(3):285-6. PubMed ID: 873878
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of ethambutol on mycobacterial cell wall permeability to hydrophobic compounds.
    Korycka-Machała M; Rumijowska-Galewicz A; Dziadek J
    Pol J Microbiol; 2005; 54(1):5-11. PubMed ID: 16209089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sensitivity of Mycobacterium fortuitum by the broth microdilution method determining the inhibitory minimal concentration].
    Ferrá Salazar C; Ramírez Alvarez MM; Montoro Cardoso E; Jiménez Misas CA; Fundora M
    Rev Cubana Med Trop; 1992; 44(2):109-12. PubMed ID: 9768199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial persistence.
    McDermott W
    Harvey Lect; 1969; 63():1-31. PubMed ID: 4902617
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bacteriostatic effect of ethambutol on tubercle bacilli sensitive or resistant to other antitubercular drugs. A modification of the vertical diffusion method for determination of biologically active ethambutol].
    Strupczewska-Januszowa H; Grzymska L; Zwolińska G
    Gruzlica; 1969 Jul; 37(7):623-8. PubMed ID: 4981782
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antitubercular effect of ethambutol in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):637-44. PubMed ID: 4981784
    [No Abstract]   [Full Text] [Related]  

  • 8. N-(chroman-4-ylidene)aryloxyacetohydrazones: synthesis and antimicrobial activity.
    Turan-Zitouni G; Kaplancikli ZA; Güven K
    Farmaco; 1997 Oct; 52(10):631-3. PubMed ID: 9507676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1968; 65():195-206. PubMed ID: 4978461
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo].
    Janowiec M; Andrzejczyk Z; Marczewska J
    Pneumonol Pol; 1989 May; 57(5):300-7. PubMed ID: 2633149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity to ethambutol and to capreomycin in wild strains of Tubercle bacilli isolated from patients previously untreated with these drugs.
    Blitek-Golc D; Zduńczyk-Pawelek H; Antosiewicz A
    Pol Med J; 1971; 10(4):945-51. PubMed ID: 5001656
    [No Abstract]   [Full Text] [Related]  

  • 14. Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents.
    Jardosh HH; Patel MP
    Eur J Med Chem; 2013 Jul; 65():348-59. PubMed ID: 23747804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 16. [Some aspects of determination of the sensitivity of Mycobacterium tuberculosis to ethambutol using a semiliquid medium].
    Manicheva OA
    Probl Tuberk Bolezn Legk; 2003; (10):47-9. PubMed ID: 14669632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tubercular agents. Part IV: Synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines.
    Kamal A; Ahmed SK; Reddy KS; Khan MN; Shetty RV; Siddhardha B; Murthy US; Khan IA; Kumar M; Sharma S; Ram AB
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5419-22. PubMed ID: 17692520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microbiological method of determination of bacterial sensitivity to combinations of antimicrobial drugs].
    Niţescu S; Herşcovici E
    Rev Med Chir Soc Med Nat Iasi; 1973; 77(4):849-53. PubMed ID: 4781137
    [No Abstract]   [Full Text] [Related]  

  • 19. [The prognostic value of the antibiogram in pulmonary tuberculosis].
    VIDAL J; GUIN JJ
    Mars Med; 1961; 98():81-92. PubMed ID: 13781201
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentiation of the effects of chlorhexidine diacetate and cetylpyridinium chloride on mycobacteria by ethambutol.
    Broadley SJ; Jenkins PA; Furr JR; Russell AD
    J Med Microbiol; 1995 Dec; 43(6):458-60. PubMed ID: 7473681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.